Clinical trials
Withdrawn Hemorrhage trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Minnesota | 3 |
| Brigham and Women's Hospital | 2 |
| Montefiore Medical Center | 2 |
| Westat | 2 |
| Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 1 |
| American University of Beirut Medical Center | 1 |
| Assiut University | 1 |
| AstraZeneca | 1 |
| Baki Topal | 1 |
| Boehringer Ingelheim | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemorrhage | 51 |
| Wounds and Injuries | 5 |
| Shock, Hemorrhagic | 4 |
| Thrombosis | 4 |
| Hemostatic Disorders | 3 |
| Hip Fractures | 3 |
| Acute Kidney Injury | 2 |
| Blood Coagulation Disorders | 2 |
| Blood Loss, Surgical | 2 |
| Postpartum Hemorrhage | 2 |
Trials
Showing 76 to 51 of 51. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.